Cha Vaccine Research Institute Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 121.87 million compared to KRW 117.32 million a year ago. Net loss was KRW 1,695.04 million compared to KRW 1,583.86 million a year ago.

Basic loss per share from continuing operations was KRW 64 compared to KRW 60 a year ago. Basic loss per share was KRW 64 compared to KRW 60 a year ago.